116 related articles for article (PubMed ID: 8559512)
1. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
Ionova D; Zlatarska S; Kirjakov Z
Nephrol Dial Transplant; 1995; 10(9):1782. PubMed ID: 8559512
[No Abstract] [Full Text] [Related]
2. Plasma hydroxyproline in renal osteodystrophy.
Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
[No Abstract] [Full Text] [Related]
3. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
Goulding A; McChesney R; Irvine RO; Dixon SR
N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
[No Abstract] [Full Text] [Related]
4. Parathyroid suppressibility in renal osteodystrophy.
Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Ku G; Sweatman AJ; Wills MR
Proc Eur Dial Transplant Assoc; 1975; 11():465-72. PubMed ID: 1197271
[No Abstract] [Full Text] [Related]
5. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
[No Abstract] [Full Text] [Related]
6. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
[No Abstract] [Full Text] [Related]
7. 1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.
Postlethwaite RJ; Houston IB
Calcif Tissue Res; 1977 May; 22 Suppl():371-5. PubMed ID: 912549
[No Abstract] [Full Text] [Related]
8. Propranolol and uraemic osteodystrophy.
Brancaccio D; Galmozzi C; Casati S; Rurale D; Belloli S; Aroldi A; Graziani G; Ponticelli C
Proc Eur Dial Transplant Assoc; 1979; 16():668-71. PubMed ID: 549007
[No Abstract] [Full Text] [Related]
9. Effect of calcitonin on hemodialysis patients with hypercalcemia and renal osteodystrophy.
Carney SL; Epstein MT
Uremia Invest; 1984-1985; 8(2):97-101. PubMed ID: 6537690
[TBL] [Abstract][Full Text] [Related]
10. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
[No Abstract] [Full Text] [Related]
11. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
Winney RJ; Bone JM; Anderson TJ; Robson JS
Calcif Tissue Res; 1977 May; 22 Suppl():94-100. PubMed ID: 912593
[No Abstract] [Full Text] [Related]
12. A trial of calcitonin therapy in renal osteodystrophy.
Delano BG; Baker R; Gardner B; Wallach S
Nephron; 1973; 11(5):287-93. PubMed ID: 4753519
[No Abstract] [Full Text] [Related]
13. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
[No Abstract] [Full Text] [Related]
14. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
[TBL] [Abstract][Full Text] [Related]
15. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
16. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Van Kesteren RG; Duursma SA; Dorhout Mees EJ
Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
[No Abstract] [Full Text] [Related]
17. Long-term treatment of uraemic osteodystrophy with 1-alpha-hydroxycholecalciferol.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Proc Eur Dial Transplant Assoc; 1976; 12():221-6. PubMed ID: 935114
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
Henderson RG; Russell RG; Ledingham JG; Smith R; Oliver DO; Walton RJ; Small DG; Preston C; Warner GT
Lancet; 1974 Mar; 1(7854):379-84. PubMed ID: 4131033
[No Abstract] [Full Text] [Related]
19. [Limited results in the treatment with salmon calcitonin in subjects with renal osteodystrophy].
Carcheri G; Falletti P; Fraguglia C; Ervo R; Lupo S; Cravino GL
Clin Ter; 1986 Feb; 116(3):195-9. PubMed ID: 3698527
[No Abstract] [Full Text] [Related]
20. Renal osteodystrophy and its treatment.
Duursma SA; Mees EJ
Neth J Med; 1973; 16(2):101-7. PubMed ID: 4705764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
